Sopheon « Terug naar discussie overzicht

Sopheon augustus 2023

9 Posts
[verwijderd]
0
pendo, gaat ook acclaim producten gebruiken van soof, dus pendo kan ook op het lijstje.
marblesthegame
0
quote:

hunky schreef op 1 augustus 2023 18:06:

pendo, gaat ook acclaim producten gebruiken van soof, dus pendo kan ook op het lijstje.
www.sopheon.com/about/press-releases/...
Arie de Beuker
0
Van wie zijn deze ruim 300k aandelen overgenomen? Zoveel handel was er niet.

Gr
Arie de Beuker
OVI
0
www.sopheon.com/hubfs/Financial%20Rel...

INTERIM RESULTS FOR THE 6 MONTHS TO 30 JUNE 2023
Sopheon, the InnovationOps software company, announces its unaudited half-yearly financial report for
the six months ended 30 June 2023 (“H1” or “the Period”) together with a business review and outlook
statement for the second half of the year.
HIGHLIGHTS:
• Revenue was $17.0m compared to $15.7m in H1 2022, reflecting a strong recurring revenue
performance.
• Five new enterprise customers were signed in the period for our flagship Accolade® software.
Sales team activity also included orders for Acclaim™ Projects and Acclaim Ideas, acquired with
ROI Blueprints and Solverboard respectively. Our online sales channel for Acclaim Ideas and
Acclaim Products, introduced in September 2022, has shown continued growth with signup
activity rising from a cold start to benchmark run rates. We will continue to refine product and
marketing methodologies to achieve conversion.
• SaaS ARR1 of $15.2m at 30 June (H1 2022: $9.3m) representing an impressive 63% year over
year growth. All new customers signed in the period were SaaS based.
• Total ARR including maintenance was $25.9m at 30 June (H1 2022: $21.9m) representing 18%
year-on-year growth. Gross ARR retention for the Period was almost 99% (H1 2022: 98%).
• Full year 2023 revenue visibility2
stands at $32.4m compared to $34.1m at this time last year.
Last year’s comparative included over $4m from a substantial perpetual license order from the
US Navy, received in July 2022. The current sales pipeline for the balance of 2023 includes
opportunities for two significant perpetual extension orders from existing military customers, as
well as many SaaS opportunities from private sector prospects and existing customers.
• Adjusted EBITDA3 of $2.9m (H1 2022: $2.9m) reflects continued investment in product and
commercial initiatives as per operating plans. Net cash at 30 June was $22.4m (H1 2022: $23.5m)
and the Group remains debt free.
• In February 2023, Barney Kent, former Chief Operating Officer of Ideagen plc was appointed to
the board as a Non-Executive Director, underlining the Company’s commitment to continued
board independence, organic growth and M&A activities.
• Several product releases were made during the Period, with AI capabilities now introduced to two
of our offerings. As noted above, sales were booked for Acclaim Projects and Acclaim Ideas
alongside Accolade, underpinning Sopheon’s strategy to be the leading software vendor focused
on operationalizing the business of innovation, commonly referred to as “InnovationOps.”
• Post Period end, in July 2023, we acquired Prodex, Sopheon’s reseller for Australia, New Zealand
and South-East Asia, for initial consideration of $0.7m. Sopheon's third acquisition since 2021
brings us a truly global footprint, with a strong platform to advance customer acquisition and
growth in the Asia Pacific region.
Sopheon’s Executive Chairman, Andy Michuda said: “Sopheon continues to deliver on its key
growth and transformation objectives, demonstrated in particular by significant and sustained increases
in SaaS ARR, supported by continued high retention performance. In parallel we have delivered
substantial investment in growth initiatives and M&A that expand our product offering, geographical
footprint and market opportunity, while maintaining cashflow discipline and EBITDA performance. Our
strong balance sheet continues to support our ability to execute with confidence. We expect the impact
of increased investments in both marketing and product to contribute to a stronger sales pipeline in the
second half of the year and beyond, in support of our growth objectives.”
9 Posts
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

AEX 882,63 +12,36 +1,42% 26 apr
AMX 914,42 -2,12 -0,23% 26 apr
ASCX 1.198,74 +7,95 +0,67% 26 apr
BEL 20 3.874,87 +16,93 +0,44% 26 apr
Germany40^ 18.177,90 +260,62 +1,45% 26 apr
US30^ 38.211,61 0,00 0,00% 26 apr
US500^ 5.095,29 0,00 0,00% 26 apr
Nasd100^ 17.698,09 0,00 0,00% 26 apr
Japan225^ 38.345,55 0,00 0,00% 26 apr
WTI 83,64 0,00 0,00% 26 apr
Brent 87,99 0,00 0,00% 26 apr
EUR/USD 1,0693 -0,0001 0,00% 27 apr
BTC/USD 63.490,70 -489,17 -0,76% 02:21
Gold spot 2.337,95 0,00 0,00% 26 apr
#/^ Index indications calculated real time, zie disclaimer
HOGE RENDEMENTEN OP DE IEX-MODELPORTEFEUILLES > WORD NU ABONNEE EN PROFITEER VAN MAAR LIEFST 67% KORTING!

Stijgers & Dalers

Stijgers Laatst +/- % tijd
ASMI 623,800 +42,200 +7,26% 26 apr
ASML 858,800 +25,100 +3,01% 26 apr
PROSUS 31,625 +0,815 +2,65% 26 apr
Dalers Laatst +/- % tijd
IMCD 141,700 -7,300 -4,90% 26 apr
ABN AMRO BANK N.V. 15,210 -0,665 -4,19% 26 apr
BESI 130,400 -5,600 -4,12% 26 apr

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront